Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-13

Clinical Trial Update: Pragmatic Trial Comparing Weight Gain in Children With Autism Taking Risperidone Versus Aripiprazole [Phase 4]

View source ↗

Summary

A Phase 4 pragmatic trial comparing weight gain in children with autism treated with risperidone versus aripiprazole has completed. The study was sponsored by V…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abilify (aripiprazole)
  • Risperdal (risperidone)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Weight Gain, Autism Spectrum Disorder | Phase 4 | Status: COMPLETED